Douglas Levinson

Doug Levinson is a science-driven, serial entrepreneur who’s created and led numerous successful life science companies. Prior to founding Fount Bio, Doug founded and served as CEO Cytrellis Biosystems, which developed an FDA-cleared, proprietary system for the aesthetic dermatology market; T2 Biosystems (TTOO), a commercial-stage diagnostics company based on nano technology; and YourBio Health, a company that develops safe and simple-to-use devices for blood collection and diagnostics. Doug served as a partner at Flagship Ventures where he was a member of the life sciences investment team. Prior to Flagship, Doug was a founding team member of TransForm Pharmaceuticals, serving on the management team until the company was acquired by J&J, and Millennium Pharmaceuticals (acquired by Takeda). Doug holds a Ph.D. in genetics from Harvard University.